Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Russneft to supply oil to UAE for $400 million

7/5/24 RNFT

VTB to buy fractional shares from minority shareholders

7/5/24 VTBR

InterRAO to compete for ₽54 billion project

7/5/24 IRAO

VTB plans to buy Russian Post's stake in Pochta Bank

7/5/24 VTBR

IPO VseInstrumenty passed on the lower boundary

7/5/24 VSEH

Shareholders of Element approved dividends for 2023

7/4/24 ELMT

Shareholders of United Heavy Machinery approved dividends for 2023

7/4/24 OMZZP

Shareholders of Novorossiysk Commercial Sea Port approved dividends for 2023

7/4/24 NMTP

Samolet is thinking about the IPO of the IT part of the business

7/4/24 SMLT

Samolet is working on the economic efficiency of sites in the Moscow region

7/4/24 SMLT